MindMed Plans to Use the Phase 1 Study to Experiment with Dosing Methods to Better Understand How Humans React to Ayahuasca's Active Ingredient, DMT The Phase 1 Clinical Trials Will... read more →
The Flow of Good News Continues for Advocates of Psilocybin aka Magic Mushrooms According to a New Poll, Roughly Half of Colorado Voters Are Likely to Support a Measure to... read more →
Researchers Are Discovering More Positive Aspects of Psychedelics as They Continue Their Work to Medicalize Psychedelic Substances as Treatments for Conditions of Mental Health But Psychedelics Can Also Be Used... read more →
If You’ve Ever Done Magic Mushrooms, You Know That Your Ego — or Your Sense of ‘Self’ — Can Melt Away as Quickly as the Wallpaper Seems to For Many,... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelics Industry News Stories for the Week of June 8th – 14th, 2020.... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 8th – 14th, 2020.... read more →
After Getting Off to a Good Start as a Psychotherapeutic Tool By the Middle of the Last Century, It Looked Like Psychedelics Would Become Part of the Medical Mainstream Then... read more →
It's Been an Incredible Year to Date for the Psychedelics Leader Champignon Brands, Here's a List of the Company's Top Accomplishments and Milestones Over the Last Quarter Also, the Company... read more →
The Champignon Brands Offering Included the Full Exercise of Options Granted to the Deal's Underwriters Proceeds of the Financing Will Allow the Psychedelics Leader to Accelerate its North American Clinical... read more →
With the New Dalriada Partnership, Champignon Expects to Develop a Robust Pipeline of Preclinical and Clinical Assets with Strong IP Protection Dalriada’s Medicinal Chemistry Expertise Combined with Champignon’s Innovative Formulation... read more →
